Smoking and asthma: Clinical and radiologic features, lung function, and airway inflammation

Chest

Volumn 129, Issue 3, 2006, Pages 661-668

  Boulet, Louis Philippe ^a   Lemière, Catherine ^b   Archambault, Francine ^a   Carrier, Guy ^a   Descary, Marie Claire ^b   Deschesnes, Francine ^a  

^a LAVAL UNIVERSITY   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Asthma; COPD; Exhaled breath condensate; High resolution CT; Induced sputum; Lung diffusion capacity; pH; Respiratory symptoms; Smoking

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOLOGY; SMOKING HABIT;

EID: 33645131645     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.3.661     Document Type: Article

References (51)

1. Holgate ST. The epidemic of asthma and allergy. J R Soc Med 2004; 97:103-110
2. Busse WW, Rosenwasser LJ. Mechanisms of asthma. J Allergy Clin Immunol 2003; 111:8799-8804
3. Althuis M, Sexton M, Prybylski D. Cigarette smoking and asthma severity among adult asthmatics. J Asthma 1999; 36:257-264
4. Ulrik CS, Lange P. Cigarette smoking and asthma. Monaldi Arch Chest Dis 2001; 56:349-353
5. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121:121S-126S
6. Zevin S, Saunders S, Gourlay SG, et al. Cardiovascular effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol 2001; 38:1633-1638
7. Miller LG, Goldstein G, Murphy M, et al. Reversible alterations in immunoregulatory T cells in smoking. Chest 1982; 5:526-529
8. Lange P, Parner J, Vestbo J, et al. A 15 year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-1200
9. Siroux V, Pin I, Oryszczyn M, et al. Relationships of active smoking to asthma and asthma severity in the EGEA study. Eur Respir J 2000; 15:470-477
10. Wakefield M, Ruffin R, Campbell D, et al. Smoking-related beliefs and behaviour among adults with asthma in a representative population sample. Aust N Z J Med 1995; 25:12-17
11. Rutgers SR, Ten Hacken NH, Koeter GH, et al. Borg scores before and after challenge with adenosine 5′ monophosphate and methacholine in subjects with COPD and asthma. Eur Respir J 2000; 16:486-490
12. Janson-Bjerklie S, Ruma SS, Stulbarg M, et al. Predictors of dyspnea intensity in asthma. Nurs Res 1987; 36:179-183
13. Thomson NC, Chaudhuri R, Livingston E. Active cigarette smoking and asthma. Clin Exp Allergy 2003; 33:1471-1475
14. Casale TB, Rhodes BJ, Donnelly AL, et al. Airway responses to methacholine in asymptomatic nonatopic cigarette smokers. J Appl Physiol 1987; 62:1888-1892
15. Marco M, Minette A. Lung function changes in smokers with normal conventional spirometry. Am Rev Respir Dis 1976; 114:723-738
16. Bosken CH, Hards J, Gatter K, et al. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immuno-histochemistry. Am Rev Respir Dis 1992; 145:911-917
17. Chalmers GW, MacLeod KJ, Thomson L, et al. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120:1917-1922
18. Pedersen B, Dahl R, Karlstrom R, et al. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide: the impact of smoking. Am J Respir Crit Care Med 1996; 153:1519-1529
19. American Thoracic Society. Standards for the diagnosis of patients with COPD and asthma. Am Rev Respir Dis 1987; 136:225-244
20. Boulet LP, Boulet V, Milot J. How should we quantify asthma control: a proposal. Chest 2002; 122:2217-2223
21. Juniper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902-907
22. Juniper EF, Guyatt GH, Cox FM, et al. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999; 14:32-38
23. Pepys J. Skin testing. Br J Hosp Med 1975; 14:412-417
24. ATS statement. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987; 136:1285-1298
25. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127:725-734
26. Clausen JL, ed. Pulmonary function testing: guidelines and controversies. Toronto, Canada: Academic Press, 1982; 193-204
27. Juniper EF, Cockcroft DW, Hargreave FE. Histamine and methacholine inhalation tests: tidal breathing method; laboratory procedure and standardization. Lund, Sweden: AB Draco, 1991
28. Boulet LP, Leblanc P, Turcotte H. Perception scoring of induced bronchoconstriction as an index of awareness of asthma symptoms. Chest 1994; 105:1430-1433
29. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154:308-317
30. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002; 110:28-34
31. Boulet LP, Turcotte H, Carrier G, et al. Increased maximal airway response to methacholine during seasonal allergic rhinitis in nonasthmatic subjects: relationships with airway wall thickness and inflammation. Eur Respir J 1995; 8:913-921
32. King GG, Muller NL, Pare PD. Evaluation of airways in obstructive pulmonary disease using high-resolution computed tomography. Am J Respir Crit Care Med 1999; 159:992-1004
33. Naidich DP, McCauley DI, Khouri NF, et al. Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982; 6:437-444
34. Foster WL Jr, Pratt PC, Roggli VL, et al. Centrilobular emphysema: CT-pathologic correlation. Radiology 1986; 159:27-32
35. Naidich DP, Zerhouni EA, Siegelman SS. Computed tomography of the thorax. New York, NY: Raven Press, 1984; 123-134, 207-240
36. Niimi A, Matsumoto H, Amitani R, et al. Airway wall thickness in asthma assessed by computed tomography: relation to clinical indices. Am J Respir Crit Care Med 2000; 162:1518-1523
37. Juniper EF, Svensson K, Mork AC, et al. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99:553-558
38. Sippel JM, Pedula KL, Vollmer WM, et al. Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest 1999; 115:691-696
39. O'Donnell DE, Bertley JC, Chau KC, et al. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155:109-115
40. Lams BEA, Sousa AR, Rees PJ, et al. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:1518-1523
41. Sunyer J, Springer G, Jamieson B, et al. Effects of asthma on cell components in peripheral blood among smokers and non-smokers. Clin Exp Allergy 2003; 33:1500-1505
42. van Beurden WJ, Dekhuijzen PN, Smeenk FW. Exhaled biomarkers in COPD: their potential role in diagnosis, treatment and prognosis. Monaldi Arch Chest Dis 2002; 57:258-267
43. Park JW, Hong YK, Kim CW, et al. High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J Investig Allergol Clin Immunol 1997; 7:186-192
44. Paganin F, Jaffuel D, Bousquet J. Significance of emphysema observed on computed tomography scan in asthma. Eur Respir J 1997; 10:2446-2448
45. Kondoh Y, Tanaguchi H, Yokohama S, et al. Emphysematous change in chronic asthma in relation to cigarette smoking: assessment by computed tomography. Chest 1990; 97:845-849
46. Boulet LP, Turcotte H, Hudon C, et al. Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD. Can Respir J 1998; 5:270-277
47. Chaudhuri R, Livingston E, McMahon AD, et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168:1308-1311
48. Barnes PJ, Ito K, Adcock IM. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 2004; 363:731-733
49. Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542-548
50. Culpitt SV, Maziak W, Loukidis S, et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1635-1639
51. Buist AS. Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes. Eur Respir J Suppl 2003; 39:30s-35s